- Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agentsNiveditha Mohan
Avera Research Institute, Sioux Falls, South Dakota 57105, USA
J Rheumatol 31:1955-8. 2004..To describe the clinical features of leukocytoclastic vasculitis (LCV) associated with the use of tumor necrosis factor-alpha (TNF-alpha) blockers...
- Spectrum of giant cell vasculitisN Mohan
Department of Rheumatology, Veterans Affairs Medical Center, 50 Irving Street, Washington DC 20422, USA
Curr Rheumatol Rep 2:390-5. 2000..The concept of the involved artery as an active participant in the events leading to luminal obstruction has been realized and provides the opportunity to evaluate novel therapies to modify the course of the disease...
- Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritidesN Mohan
Georgetown University Medical Center, Washington, DC 20007, USA
Arthritis Rheum 44:2862-9. 2001..To review the occurrence of neurologic events suggestive of demyelination during anti-tumor necrosis factor alpha (anti-TNFalpha) therapy for inflammatory arthritides...
- ANCA-associated small vessel vasculitis: clinical and therapeutic advancesNiveditha Mohan
University of Pittsburgh, Arthritis and Autoimmunity Center, Pittsburgh, PA 15213, USA
Curr Rheumatol Rep 12:406-13. 2010..However, challenges remain in limiting disease flares and therapy-associated morbidities, and cures are achieved only in cases in which a clear culprit exists...